| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.093 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.2 |